The effect of large doses of a synthetic progestogen upon endometrial cancer and upon steroid metabolism
Simm, S.; Kedzia, H.; Michalkiewicz, M.; Przybora, L.
International Journal of Gynecology and Obstetrics 9(2): 68-75
1971
ISSN/ISBN: 0020-7292 DOI: 10.1002/j.1879-3479.1971.tb00772.xDocument Number: 487321
Document emailed within 0-6 h
Related Documents
Thurzó, L. 1990: Response of estrogen and progesterone receptors to treatment with large doses of progestogen (depo-provera) in endometrial cancer Zentralblatt für Gynakologie 112(17): 1111-1115Guleria, K.; Agarwal, N.; Mishra, K.; Gulati, R.; Mehendiratta, A. 2004: Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer? Journal of Obstetrics and Gynaecology Research 30(3): 181-187
Cade, T.J.; Quinn, M.A.; Rome, R.M.; Neesham, D. 2013: Long-term outcomes after progestogen treatment for early endometrial cancer Australian and New Zealand Journal of Obstetrics and Gynaecology 53(6): 566-570
Adlercreutz, H.; Pulkkinen, M.O.; Hämäläinen, E.K.; Korpela, J.T. 1984: Studies on the role of intestinal bacteria in metabolism of synthetic and natural steroid hormones Journal of Steroid Biochemistry 20(1): 217-229
Sadoff, L.; Lusk, W. 1974: The effect of large doses of medroxyprogesterone acetate (MPA) on urinary estrogen levels and serum levels of cortisol T4 LH and testosterone in patients with advanced cancer Obstetrics and Gynecology 43(2): 262-267
Alexandrescu, D.T.; Bhagwati, N.S.; Fomberstein, B.; Wolfe, D.E.; Feliz, A.; Wiernik, P.H. 2005: Steroid-responsive inclusion body myositis associated with endometrial cancer Clinical and Experimental Rheumatology 23(1): 93-96
1987: Combination oral contraceptive use and the risk of endometrial cancer. The Cancer and Steroid Hormone Study of the Centers for Disease Control and the National Institute of Child Health and Human Development JAMA 257(6): 796-800
Köbberling, J.; zur Mühlen A von; Emrich, D.; Hesch, R.D. 1971: Studies on the effect of synthetic "thyrotropin releasing factor" (TRF) in varying doses and administration forms Verhandlungen der Deutschen Gesellschaft für Innere Medizin 77: 644-646
Rozenbaum, H. 1983: Choosing the right synthetic progestogen Contraception Fertilite Sexualite 11(11): 1233-1242
Kryński, J.; Wyszyńska, T. 1985: Evaluation of the effectiveness of bolus doses of prednisolone in steroid-resistant and steroid-dependent nephrotic syndrome in children Pediatria Polska 60(2): 163-168
Badiugin, I.S. 1965: Antishock effect of large doses of cyanocobalamin Biulleten' Eksperimental'noi Biologii i Meditsiny 60(11): 62-64
1991: Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(2): 186-190
1991: Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(2): 186-190
1991: Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. The WHO Collaborative Study of Neoplasia and Steroid Contraceptives International Journal of Cancer 49(2): 186-190
Tanaka, S.; Shirai, K.; Fujita, M.; Ohe, Y.; Furuta, Y. 1978: Effect of large doses of morphine on mechanics of breathing Masui. Japanese Journal of Anesthesiology 27(8): 843-848
Juhász, L.; Csák, L.; Váci, I.; Kassay, L.; Strausz, J. 1980: The effect of large doses of psychopharmaca over a prolonged period on the liver Orvosi Hetilap 121(9): 517-519
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Hoffman, M.; Shapiro, S.; Kelly, J.P.; Cooper, D.; Carrara, H.; Williamson, A.; Denny, L.; Dutoit, G.; Allan, B.; Stander, I.; Rosenberg, L. 2003: Risk of invasive cervical cancer in relation to use of injectable progestogen contraceptives and combined estrogen/progestogen contraceptives American Journal of Epidemiology 157(11 Suppl): S11
Shapiro, S.; Rosenberg, L.; Hoffman, M.; Kelly, J.P.; Cooper, D.D.; Carrara, H.; Denny, L.E.; du Toit, G.; Allan, B.R.; Stander, I.A.; Williamson, A-Lise. 2003: Risk of invasive cancer of the cervix in relation to the use of injectable progestogen contraceptives and combined estrogen/progestogen oral contraceptives (South Africa) Cancer Causes and Control: Ccc 14(5): 485-495